Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication July 8, 2005
- Accepted for publication November 10, 2005
- Published online February 1, 2006.
Copyright & Usage
© 2006 by Society of Nuclear Medicine
Author Information
- Samer Ezziddin, MD 1 ,
- Timur Logvinski, MD 1 ,
- Charlotte Yong-Hing, MD 2 ,
- Hojjat Ahmadzadehfar, MD 1 ,
- Hans-Peter Fischer, MD 3 ,
- Holger Palmedo, MD 1 ,
- Jan Bucerius, MD 1 ,
- Michael J. Reinhardt, MD 1 and
- Hans-Jürgen Biersack, MD 1
- 1Department of Nuclear Medicine, University of Bonn, Bonn, Germany; 2Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada; and 3Department of Pathology, University of Bonn, Bonn, Germany
- For correspondence or reprints contact: Samer Ezziddin, MD, Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Strasse 25, 53115 Bonn, Germany E-mail: samer.ezziddin{at}ukb.uni-bonn.de
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- A Peptide Meets a Radionuclide to Combat a Rare Tumor
- Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma
- Long-Term Outcome and Toxicity After Dose-Intensified Treatment with 131I-MIBG for Advanced Metastatic Carcinoid Tumors
- Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy
- Nuclear medicine imaging of neuroendocrine tumours
- Response and Long-Term Control of Bone Metastases After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
- Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
- Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin
- Predictive Value of 18F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors
- Utility of Radiolabeled Somatostatin Receptor Analogues for Staging/Restaging and Treatment of Somatostatin Receptor-Positive Pediatric Tumors
- Imaging hNET Reporter Gene Expression with 124I-MIBG